Australian researchers have laid to rest a longstanding controversy: is the womb sterile? They carefully collected amniotic fluid samples from 50 healthy women undergoing planned Caesarean deliveries, and found that nearly all (36/43 viable samples) contained bacterial DNA. What's more, all 50 newborns had bacteria in their first poop.
Published in Frontiers in Microbiology, the study used uniquely rigorous contamination controls to confirm that exposure to bacteria begins in the womb - and could help to shape the developing fetal immune system, gut and brain.
"Over the last decade, numerous studies have detected bacterial DNA in amniotic fluid and first-pass meconium [baby's first poop], challenging the long-held assumption that the womb is sterile," explains lead author Lisa Stinson, of the University of Western Australia. "However, some argue that the results are false positives - contaminants in the reagents used in DNA analysis."
It is important to conclusively determine whether the healthy womb harbors bacteria, say the researchers, because this 'fetal microbiome' would likely have a significant impact on the developing immune system, gut, and brain.
To settle the issue, Stinson and colleagues took strict measures to eliminate bacterial contamination when analyzing amniotic fluid and meconium samples. For example, they purified the reagents used to amplify traces of bacterial DNA in the samples, by adding an enzyme which digests DNA remnants from biomanufacturing.
"Despite these measures, we still found bacterial DNA in almost all samples," reports Stinson. "Interestingly, the meconium microbiome varied hugely between individual newborns. The amniotic fluid microbiome for the most part contained typical skin bacteria, such as Propionibacterium acnes and Staphylococcus species."
But what might these bacteria be doing in the womb?
None of these women or their babies had any sign of infection. In fact, the fetal microbiome may prove to be a beneficial regulator of early development.
"We found that levels of important immune modulators in meconium and inflammatory mediators in amniotic fluid varied according to the amount and species of bacterial DNA present. This suggests that the fetal microbiome has the potential to influence the developing fetal immune system."
There is one small caveat -- technically, the DNA in these samples could have come from bacteria that were already dead in the womb.
"Here we've proven that bacterial DNA is present in the womb, but the next step will be to show whether these are alive and constitute a true microbiome," concludes Stinson.
Source: Frontiers
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.